As global markets navigate a complex landscape marked by interest rate adjustments and mixed economic signals, investors are increasingly looking for stable sources of income amid volatility. In this environment, dividend stocks can provide a reliable income stream, making them an attractive consideration for those looking to balance growth with stable returns.
|
Name |
Dividend yield |
Dividend assessment |
|
Tsubakimoto chain (TSE:6371) |
4.27% |
★★★★★★ |
|
Wuliangye YibinLtd (SZSE:000858) |
3.22% |
★★★★★★ |
|
CAC holdings (TSE:4725) |
4.76% |
★★★★★★ |
|
Yamato Kogyo (TSE:5444) |
4.11% |
★★★★★★ |
|
Guangxi LiuYao Group (SHSE:603368) |
3.23% |
★★★★★★ |
|
Padma Oil (DSE:PADMAOIL) |
7.43% |
★★★★★★ |
|
Nihon parking (TSE:4095) |
3.97% |
★★★★★★ |
|
China South Publishing & Media Group (SHSE:601098) |
3.80% |
★★★★★★ |
|
HUAYU Automotive Systems (SHSE:600741) |
4.19% |
★★★★★★ |
|
EJ Holdings (TSE:2153) |
3.88% |
★★★★★★ |
Click here to see the full list of 1,868 stocks from our Top Dividend Stocks screener.
Below we present a selection of stocks filtered out by our screen.
Simply Wall St dividend rating: ★★★★☆☆
Overview: Abu Dhabi Commercial Bank PJSC, together with its subsidiaries, provides consumer banking, wholesale banking and treasury and investment services in the United Arab Emirates and internationally, with a market capitalization of AED75.08 billion.
Operations: Abu Dhabi Commercial Bank PJSC's revenue segments include Retail Banking (AED4.69 billion), Investments and Treasury (AED5.04 billion), and Corporate and Investment Banking (AED5.71 billion), along with Property Management contributing AED745.08 million .
Dividend yield: 5.5%
Abu Dhabi Commercial Bank PJSC's dividend payments have been volatile over the past decade, presenting challenges for income-oriented investors. Despite a low payout ratio of 46.9%, indicating that dividends are more than covered by profits, the bank's provision for bad loans is below ideal levels at 99%. The recent earnings growth, with net profit rising to AED 2.39 billion in Q3 2024, compared to AED 1.94 billion a year ago, provides some optimism about the future sustainability of the dividend.
Simply Wall St dividend rating: ★★★★☆☆
Overview: JW Lifescience Corporation specializes in providing infusion solutions both in South Korea and internationally, with a market capitalization of ₩179.78 billion.
Operations: JW Lifescience Corporation generates revenues primarily from its pharmaceutical segment, amounting to ₩221.32 billion.
